HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc. is a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform.

$0.76  -0.04 (-5.51%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/18/2019
Outstanding shares:  2,399,517
Average volume:  134,757
Market cap:   $1,932,811
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ5K4M7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%